Surgeon General Joseph Ladapo Slams Doctors for ‘Blindly Following Big Pharma’ After ‘Concerning Rate of Serious Adverse Events’ Vax Study

Published Sep. 2, 2022, 2:09 p.m. ET | Updated Sep. 2, 2022

ladapo new2

TALLAHASSEE (FLV) – Florida Surgeon General Joseph Ladapo slammed Pfizer, Moderna, Big Pharma, and doctors who “blindly follow” the pharmaceutical mega-corporations in light of a new study.

“New study published in #Vaccine shows concerning rate of serious adverse events after mRNA vaccination, but estimates are limited b/c @pfizer & @moderna_tx won’t release patient-level trial data,” Ladapo said. “Why are doctors blindly following Big Pharma?

Ladapo linked to a randomized trial study looking into “serious adverse events of special interest following mRNA COVID-19 vaccination” by researchers from the U.S., Spain, and Australia. It was made available online on Aug. 31, 2022.

The results of the study say mRNA COVID-19 vaccines from Pfizer and Moderna “were associated with an excess risk of serious adverse events of special interest,” according to their data.

“The excess risk of serious adverse events found in our study points to the need for formal harm-benefit analyses, particularly those that are stratified according to risk of serious COVID-19 outcomes,” they say. “These analyses will require public release of participant level datasets.”

In Aug., Ladapo continued his rhetoric against the medical establishment for, what he says, is refusing to ask questions and conduct quality research on negative ramifications of the COVID-19 vaccines.

“A pre-print from Thailand found that 3.5% of adolescent boys had overt or subclinical myocarditis after getting the second dose of the COVID-19 vaccine. Is @CDCGov doing similar prospective study in the US? Is anyone?” the Surgeon General questioned on Twitter.

breakdown of the study from Vinay Prasad, an associate professor on various medical subfields, slams policymakers and leaders for ignoring suggestions of remedying risks of myocarditis via lower dosages, single dosages, exemptions, restrictions, setting higher bars for boosters for men, and more.

“Instead of taking any of these actions, which we suggested at the time, the public health community downplayed, gaslighted and mislead about the concern,” he wrote.

Current COVID vaccine guidance from the State of Florida warns against young people, particularly young boys, from receiving a COVID vaccination because the risks may outweigh the benefits.

“Based on currently available data, healthy children aged 5 to 17 may not benefit from receiving the currently available COVID-19 vaccine,” it says.

The Department lists multiple factors that “may” cause risks to outweigh benefits of the vaccine, including their already low risk of severe illness to COVID-19, high prevalence of immunity in children, absence of data supporting vaccination benefit on children with immunity, higher than anticipated adverse events in vaccine recipients, reduced efficacy in children 5-17, and the risk of myocarditis (heart inflammation) due to the vaccine.

It notes that children with underlying health conditions or comorbidities should be considered with their doctor.

“In general, healthy children with no significant underlying health conditions under 16 years old are at little to no risk of severe illness complications from COVID-19.”

They note that in children aged 16 to 17, the risk of myocarditis may outweigh the benefits.

One study found that the efficacy of the vaccine fell 40% over two months in children aged 12 to 17.

Another study also found the highest rates of myocarditis among males aged 12 to 15, followed by those aged 16 to 17.

For the full health guidance and links to clinical data, click here.

Share This Post

Latest News

5 1 vote
Article Rating
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments